VAXART INC. DL-,10VAXART INC. DL-,10VAXART INC. DL-,10

VAXART INC. DL-,10

No trades
See on Supercharts
Market capitalization
‪141.10 M‬EUR
−0.5210EUR
‪−74.71 M‬EUR
‪6.69 M‬EUR
‪171.57 M‬
Beta (1Y)
1.87

About VAXART INC. DL-,10

CEO
Steven Lo
Website
Headquarters
South San Francisco
Employees (FY)
125
Founded
2004
ISIN
US92243A2006
FIGI
BBG00Z5JGLR2
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded in 2004 and is headquartered in South San Francisco, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange VAXART INC. DL-,10 stocks are traded under the ticker NB11.
VAXART INC. DL-,10 is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for VAXART INC. DL-,10 has a max estimate of 7.5200 EUR and a min estimate of 1.8800 EUR.
NB11 earnings for the last quarter are −0.10 EUR whereas the estimation was −0.17 EUR which accounts for 38.89% surprise. Estimated earnings for the next quarter are −0.12 EUR. See more details about VAXART INC. DL-,10 earnings.
VAXART INC. DL-,10 revenue for the last quarter amounts to ‪1.99 M‬ EUR despite the estimated figure of ‪94.60 K‬ EUR. In the next quarter revenue is expected to reach ‪755.01 K‬ EUR.
Yes, you can track VAXART INC. DL-,10 financials in yearly and quarterly reports right on TradingView.
NB11 net income for the last quarter is ‪−15.74 M‬ EUR, while the quarter before that showed ‪−16.46 M‬ EUR of net income which accounts for 4.36% change. Track more VAXART INC. DL-,10 financial stats to get the full picture.
No, NB11 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NB11 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VAXART INC. DL-,10 stock right from TradingView charts — choose your broker and connect to your account.
NB11 reached its all-time high on Feb 3, 2021 with the price of 21.0000 EUR, and its all-time low was 0.1820 EUR and was reached on Nov 25, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 125.00 employees. See our rating of the largest employees — is VAXART INC. DL-,10 on this list?
We've gathered analysts' opinions on VAXART INC. DL-,10 future price: according to them, NB11 price has a max estimate of 7.52 EUR and a min estimate of 1.88 EUR. Read a more detailed VAXART INC. DL-,10 forecast: see what analysts think of VAXART INC. DL-,10 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VAXART INC. DL-,10 EBITDA is ‪−71.34 M‬ EUR, and current EBITDA margin is ‪−1.07 K‬%. See more stats in VAXART INC. DL-,10 financial statements.